瘤微环境敏感的金属天然多纳米酶,通过干扰葡萄糖代谢和氧化还原稳定作用来进行放射敏感化
Jiongyu Ren1, Qiang Wen1, Shiye Du1
1Department of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, PR China.
概括
这项研究引入了一种新的纳米酶,该纳米酶针对瘤微环境,以增强放射治疗. 它有效地降低葡萄糖代谢,缓解缺氧,改善癌症治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 放射治疗面临的挑战是由于瘤缺氧,抗氧化防御和高葡萄糖代谢.
- 开发有效的放射敏感剂对于提高放射治疗疗效至关重要.
研究的目的:
- 开发一种对瘤微环境 (TME) 敏感的纳米酶,用于增强放射治疗.
- 调查纳米酶克服瘤缺氧,调节葡萄糖代谢和打击抗氧化机制的能力.
主要方法:
- 合成了一种与鲁天然的多烯佛洛 (RPP) 纳米酶,具有类似葡萄糖氧化酶,催化酶,过氧化酶和谷氨过氧化酶的活性.
- 在体外和体内评估纳米酶的性能,包括它对4T1瘤细胞的影响.
- 使用正电子发射断层扫描 (PET) 图像,以验证葡萄糖吸收和缺氧的变化.
主要成果:
- 通过消耗细胞内葡萄糖和阻断细胞外葡萄糖吸收,RPP纳米酶有效地抑制了葡萄糖分解.
- 纳米酶催化过氧化转化为活性氧物种和氧气,缓解瘤缺氧.
- 下调细胞内谷氨和乳酸水平,克服抗氧化剂代谢.
- 在体外和体内显著增强4T1瘤细胞的放射敏感性.
- PET成像证实葡萄糖吸收减少和缺氧缓解.
结论:
- 通过调节TME,RPP纳米酶作为一种高效和安全的放射敏感剂.
- 这种对TME敏感的纳米酶对改善瘤放射治疗具有显著的前景.
- 纳米酶的多酶类活动为癌症治疗提供了一种新的策略.
更多相关视频
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
1.4K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.1K
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
